EUROIMMUN AG
EUROIMMUN is an international provider of medical laboratory products for autoimmune, infection, allergy, and molecular genetic diagnostics. The company’s portfolio encompasses indirect immunofluorescence assays, ELISAs, immunoblots, radioimmunoassays, chemiluminescence immunoassays (ChLIA), molecular genetic test systems, and automation technologies.
Product News
View All Product News
Microbiology Product Areas
ClinicalNOTE: The products listed in this section may not be approved for clinical diagnostic use in your jurisdiction. You must assume these products are unregulated and therefore cannot be used for routine testing and reporting of results unless otherwise stated. | ||
| Lateral Flow Assays | Show all suppliers | |
| RT-PCR | Show all suppliers | |
| SARS-CoV-2 | Show all suppliers | |
| Zika Virus | Show all suppliers | |
Get our eNewsletter
Over 7,000 microbiology professionals get our weekly eNewsletter - subscribe now and find out why!
LATEST MICROBIOLOGY NEWS
- Stop Worrying, Prepare Your Half Fraser Broth in 1 Step With Condalab!
- Steam Control GST E6 SS (BA coupons)
- Change in Board of Directors of MBV AG
- Environmental Swabbing Assay That Simultaneously Detects Both Salmonella and Listeria in One Test
- Rapid Micro Biosystems® Growth Direct® System Detects Mold in as Little as 1 Day
- Priorclave Simplifies Autoclave Selection Process
- Microbiologics Announces New CEO
- MAESTRIA™, a New Generation Microbiology Middleware Optimizes Laboratory Workflow
- How an EMS Can Help You Meet Annex 1
- Is Your Environmental Monitoring In Line With The New Annex 1?
MICROBIOLOGY EVENTS
- HypoxEU Virtual Seminar
- Using VITAL Reference Doses for Allergen Labelling
- GENAP Summit 2023
- 2023 PDA Annex 1 Workshop
- 7th Microbiome Movement - AgBioTech Summit
- Viable Air and Surface Sampling for Sterile Compounding Facilities
- Low Endotoxin Recovery/Masking - Hands-on Laboratory Training Course
- My Green Lab Europe 2023 Summit
- 2023 CMI International Microbiome Meeting (CIMM)
- Impact of New Version of Annex1 on Drug Substance and Drug Processes